Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Identification and quantitation of clinically relevant microbes in patient samples: Comparison of three k-mer based classifiers for speed, accuracy, and sensitivity.

Watts GS, Thornton JE Jr, Youens-Clark K, Ponsero AJ, Slepian MJ, Menashi E, Hu C, Deng W, Armstrong DG, Reed S, Cranmer LD, Hurwitz BL.

PLoS Comput Biol. 2019 Nov 22;15(11):e1006863. doi: 10.1371/journal.pcbi.1006863. eCollection 2019 Nov.

2.

16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria.

Watts GS, Youens-Clark K, Slepian MJ, Wolk DM, Oshiro MM, Metzger GS, Dhingra D, Cranmer LD, Hurwitz BL.

J Appl Microbiol. 2017 Dec;123(6):1584-1596. doi: 10.1111/jam.13590. Epub 2017 Nov 7.

3.

Innovative qPCR using interfacial effects to enable low threshold cycle detection and inhibition relief.

Harshman DK, Rao BM, McLain JE, Watts GS, Yoon JY.

Sci Adv. 2015 Sep 4;1(8):e1400061. doi: 10.1126/sciadv.1400061. eCollection 2015 Sep.

5.

Environmental arsenic exposure and microbiota in induced sputum.

White AG, Watts GS, Lu Z, Meza-Montenegro MM, Lutz EA, Harber P, Burgess JL.

Int J Environ Res Public Health. 2014 Feb 21;11(2):2299-313. doi: 10.3390/ijerph110202299.

6.

Maintenance of mitochondrial genomic integrity in the absence of manganese superoxide dismutase in mouse liver hepatocytes.

Cyr AR, Brown KE, McCormick ML, Coleman MC, Case AJ, Watts GS, Futscher BW, Spitz DR, Domann FE.

Redox Biol. 2013 Feb 5;1:172-7. doi: 10.1016/j.redox.2013.01.001. eCollection 2013.

7.

The matrix protein CCN1/CYR61 is required for α(V)β5-mediated cancer cell migration.

Jandova J, Beyer TE, Meuillet EJ, Watts GS.

Cell Biochem Funct. 2012 Dec;30(8):687-95. doi: 10.1002/cbf.2853. Epub 2012 Jun 13.

8.

The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid.

Roesly HB, Khan MR, Chen HD, Hill KA, Narendran N, Watts GS, Chen X, Dvorak K.

Am J Physiol Gastrointest Liver Physiol. 2012 Apr 15;302(8):G864-72. doi: 10.1152/ajpgi.00340.2011. Epub 2012 Feb 2.

9.

Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma.

Dvorak K, Watts GS, Ramsey L, Holubec H, Payne CM, Bernstein C, Jenkins GJ, Sampliner RE, Prasad A, Garewal HS, Bernstein H.

Am J Gastroenterol. 2009 Feb;104(2):302-9. doi: 10.1038/ajg.2008.85. Epub 2009 Jan 27.

10.

Agglomerative epigenetic aberrations are a common event in human breast cancer.

Novak P, Jensen T, Oshiro MM, Watts GS, Kim CJ, Futscher BW.

Cancer Res. 2008 Oct 15;68(20):8616-25. doi: 10.1158/0008-5472.CAN-08-1419.

11.

DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage.

Watts GS, Futscher BW, Holtan N, Degeest K, Domann FE, Rose SL.

BMC Med Genomics. 2008 Sep 30;1:47. doi: 10.1186/1755-8794-1-47.

12.
13.

Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma.

Watts GS, Tran NL, Berens ME, Bhattacharyya AK, Nelson MA, Montgomery EA, Sampliner RE.

Int J Cancer. 2007 Nov 15;121(10):2132-9.

14.

Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161.

Ignatenko NA, Yerushalmi HF, Watts GS, Futscher BW, Stringer DE, Marton LJ, Gerner EW.

Technol Cancer Res Treat. 2006 Dec;5(6):553-64.

PMID:
17121431
15.

Epigenetic inactivation of the HOXA gene cluster in breast cancer.

Novak P, Jensen T, Oshiro MM, Wozniak RJ, Nouzova M, Watts GS, Klimecki WT, Kim C, Futscher BW.

Cancer Res. 2006 Nov 15;66(22):10664-70. Epub 2006 Nov 6.

16.

AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.

Li H, Watts GS, Oshiro MM, Futscher BW, Domann FE.

Oncogene. 2006 Aug 31;25(39):5405-15. Epub 2006 Apr 24.

PMID:
16636674
17.

The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells.

Watts GS, Oshiro MM, Junk DJ, Wozniak RJ, Watterson S, Domann FE, Futscher BW.

Neoplasia. 2004 May-Jun;6(3):187-94.

18.

The chemopreventive agent alpha-difluoromethylornithine blocks Ki-ras-dependent tumor formation and specific gene expression in Caco-2 cells.

Ignatenko NA, Zhang H, Watts GS, Skovan BA, Stringer DE, Gerner EW.

Mol Carcinog. 2004 Apr;39(4):221-33.

PMID:
15057874
19.

Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression.

Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW.

Oncogene. 2003 Jun 5;22(23):3624-34.

PMID:
12789271
20.

Low-level arsenite induced gene expression in HEK293 cells.

Zheng XH, Watts GS, Vaught S, Gandolfi AJ.

Toxicology. 2003 May 1;187(1):39-48.

PMID:
12679051
21.

Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate.

Crowley-Weber CL, Payne CM, Gleason-Guzman M, Watts GS, Futscher B, Waltmire CN, Crowley C, Dvorakova K, Bernstein C, Craven M, Garewal H, Bernstein H.

Carcinogenesis. 2002 Dec;23(12):2063-80.

PMID:
12507930
22.

cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways.

Watts GS, Futscher BW, Isett R, Gleason-Guzman M, Kunkel MW, Salmon SE.

J Pharmacol Exp Ther. 2001 Nov;299(2):434-41.

PMID:
11602652
23.

Laminin-5-mediated gene expression in human prostate carcinoma cells.

Calaluce R, Kunkel MW, Watts GS, Schmelz M, Hao J, Barrera J, Gleason-Guzman M, Isett R, Fitchmun M, Bowden GT, Cress AE, Futscher BW, Nagle RB.

Mol Carcinog. 2001 Feb;30(2):119-29.

PMID:
11241759
25.

Detecting differences in 5-methylcytosine using restriction enzyme isoschizomers: an endogenous control for complete digestion.

Watts GS, Futscher BW.

Nucleic Acids Res. 1995 Nov 25;23(22):4740-1. No abstract available.

Supplemental Content

Loading ...
Support Center